Adaptimmune Therapeutics Plc Acciones en circulación
¿Qué es el Acciones en circulación de Adaptimmune Therapeutics Plc?
El Acciones en circulación de Adaptimmune Therapeutics Plc es 255.745M
¿Cuál es la definición de Acciones en circulación?
Las acciones en circulación son todas las acciones de una corporación o de un activo financiero que han sido autorizadas, emitidas y compradas por los inversionistas y son retenidas por ellos.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Acciones en circulación de compañías en Sector Health Care en NASDAQ en comparadas con Adaptimmune Therapeutics Plc
¿Qué hace Adaptimmune Therapeutics Plc?
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.
Empresas con acciones en circulación similar a Adaptimmune Therapeutics Plc
- China Petroleum & Chemical Corp tiene Acciones en circulación de 255.134M
- Realia Properties tiene Acciones en circulación de 255.221M
- Vertex Pharmaceuticals tiene Acciones en circulación de 255.558M
- International Flavors & Fragrances tiene Acciones en circulación de 255.659M
- Intuit tiene Acciones en circulación de 255.668M
- 9 Meters Biopharma tiene Acciones en circulación de 255.668M
- Adaptimmune Therapeutics Plc tiene Acciones en circulación de 255.745M
- Desktop Metal tiene Acciones en circulación de 255.777M
- Axion Ventures tiene Acciones en circulación de 255.894M
- REF tiene Acciones en circulación de 256.000M
- GE T&D India tiene Acciones en circulación de 256.047M
- Laurion Mineral Exploration tiene Acciones en circulación de 256.070M
- Shandong Molong Petroleum Machinery tiene Acciones en circulación de 256.126M